ANIXA BIOSCIENCES, INC. Increase (Decrease) in Receivables
ANIXA BIOSCIENCES, INC. (ANIX) reported Increase (Decrease) in Receivables of $56.00 thousand for the 6-month period ending 2026-04-30, per its 10-Q filed 2026-06-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2026-09-09
- ANIXA BIOSCIENCES, INC. increase (decrease) in receivables for the quarter ending 2025-10-31 was $0.00.
- ANIXA BIOSCIENCES, INC. increase (decrease) in receivables for the quarter ending 2025-07-31 was $0.00, a 100.00% decline year-over-year.
- ANIXA BIOSCIENCES, INC. increase (decrease) in receivables for the quarter ending 2025-04-30 was $0.00.
- ANIXA BIOSCIENCES, INC. increase (decrease) in receivables for the quarter ending 2025-01-31 was -$173.00K, a 242.98% decline year-over-year.
- ANIXA BIOSCIENCES, INC. increase (decrease) in receivables for fiscal 2025 was -$173.00K.
- ANIXA BIOSCIENCES, INC. increase (decrease) in receivables for fiscal 2024 was -$97.00K, a 143.30% decline from fiscal 2023.
- ANIXA BIOSCIENCES, INC. increase (decrease) in receivables for fiscal 2023 was $224.00K, a 672.41% increase from fiscal 2022.
- ANIXA BIOSCIENCES, INC. increase (decrease) in receivables for fiscal 2022 was $29.00K.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 9 month as first filed | Increase (Decrease) in Receivables 12 month |
|---|---|---|---|---|---|
| 2026-04-30 | $56.00K 10-Q · filed 2026-06-10 | ||||
| 2025-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | $0.00 derived: sum of 2 quarters · filed 2026-09-09 | $0.00 derived: sum of 3 quarters · filed 2026-09-09 | -$173.00K 10-K · filed 2026-01-12 | |
| 2025-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-09-09 | $0.00 derived: sum of 2 quarters · filed 2026-09-09 | -$173.00K 10-Q · filed 2026-09-09 | -$410.00K derived: sum of 4 quarters · filed 2026-09-09 | |
| 2025-04-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-06-10 | -$173.00K 10-Q · filed 2026-06-10 | -$410.00K derived: sum of 3 quarters · filed 2026-06-10 | -$218.00K derived: sum of 4 quarters · filed 2026-06-10 | |
| 2025-01-31 | -$173.00K 10-Q · filed 2025-03-11 | -$410.00K derived: sum of 2 quarters · filed 2026-01-12 | -$218.00K derived: sum of 3 quarters · filed 2026-01-12 | -$391.00K derived: sum of 4 quarters · filed 2026-01-12 | |
| 2024-10-31 | -$237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-01-12 | -$45.00K derived: sum of 2 quarters · filed 2026-01-12 | -$218.00K derived: sum of 3 quarters · filed 2026-01-12 | -$97.00K 10-K · filed 2026-01-12 | |
| 2024-07-31 | $192.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-09-10 | $19.00K derived: sum of 2 quarters · filed 2025-09-10 | $140.00K 10-Q · filed 2025-09-10 | $76.00K derived: sum of 4 quarters · filed 2025-09-10 | |
| 2024-04-30 | -$173.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-28 | -$52.00K 10-Q · filed 2025-05-28 | -$116.00K derived: sum of 3 quarters · filed 2025-05-28 | -$37.00K derived: sum of 4 quarters · filed 2025-05-28 | |
| 2024-01-31 | $121.00K 10-Q · filed 2025-03-11 | $57.00K derived: sum of 2 quarters · filed 2025-03-11 | $136.00K derived: sum of 3 quarters · filed 2025-03-11 | $245.00K derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-10-31 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-01-10 | $15.00K derived: sum of 2 quarters · filed 2025-01-10 | $124.00K derived: sum of 3 quarters · filed 2025-01-10 | $224.00K 10-K · filed 2025-01-10 | |
| 2023-07-31 | $79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-09-06 | $188.00K derived: sum of 2 quarters · filed 2024-09-06 | $288.00K 10-Q · filed 2024-09-06 | ||
| 2023-04-30 | $109.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-06-04 | $209.00K 10-Q · filed 2024-06-04 | |||
| 2023-01-31 | $100.00K 10-Q · filed 2024-03-12 | ||||
| 2022-10-31 | $29.00K 10-K · filed 2024-01-16 | ||||
| 2020-10-31 | -$3.72K derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-07 | -$30.11K derived: sum of 2 quarters · filed 2021-09-01 | -$20.08K derived: sum of 3 quarters · filed 2021-09-01 | -$64.30K 10-K · filed 2021-01-07 | |
| 2020-07-31 | -$26.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-09-01 | -$16.36K derived: sum of 2 quarters · filed 2021-09-01 | -$60.58K 10-Q · filed 2021-09-01 | $60.58K 10-Q · filed 2020-09-08 | -$638.20K derived: sum of 4 quarters · filed 2021-09-01 |
| 2020-04-30 | $10.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-06-09 | -$34.19K 10-Q · filed 2020-06-09 | -$611.81K derived: sum of 3 quarters · filed 2021-01-07 | -$795.85K derived: sum of 4 quarters · filed 2021-01-07 | |
| 2020-01-31 | -$44.22K 10-Q · filed 2020-03-09 | -$621.84K derived: sum of 2 quarters · filed 2021-01-07 | -$805.88K derived: sum of 3 quarters · filed 2021-01-07 | -$112.02K derived: sum of 4 quarters · filed 2021-01-07 | |
| 2019-10-31 | -$577.62K derived: 10-K 12 month − 10-Q 9 month · filed 2021-01-07 | -$761.66K derived: sum of 2 quarters · filed 2021-01-07 | -$67.80K derived: sum of 3 quarters · filed 2021-01-07 | -$271.70K 10-K · filed 2021-01-07 | |
| 2019-07-31 | -$184.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-09-08 | $509.82K derived: sum of 2 quarters · filed 2020-09-08 | $305.92K 10-Q · filed 2020-09-08 | -$305.92K 10-Q · filed 2019-09-06 | $524.20K derived: sum of 4 quarters · filed 2020-09-08 |
| 2019-04-30 | $693.86K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-06-09 | $489.96K 10-Q · filed 2020-06-09 | $708.24K derived: sum of 3 quarters · filed 2020-06-09 | $707.07K derived: sum of 4 quarters · filed 2020-06-09 | |
| 2019-01-31 | -$203.90K 10-Q · filed 2020-03-09 | $14.38K derived: sum of 2 quarters · filed 2020-03-09 | $13.21K derived: sum of 3 quarters · filed 2020-03-09 | ||
| 2018-10-31 | $218.28K derived: 10-K 12 month − 10-Q 9 month · filed 2020-01-09 | $217.10K derived: sum of 2 quarters · filed 2020-01-09 | $258.99K 10-K · filed 2020-01-09 | ||
| 2018-07-31 | -$1.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-09-06 | $40.71K 10-Q · filed 2019-09-06 | |||
| 2018-04-30 | $41.89K 10-Q · filed 2019-06-12 | ||||
| 2015-01-31 | -$355.00K 10-Q · filed 2016-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |